Cohen Margot E, Salmasian Hojjat, Li Jianhua, Liu Jianfang, Zachariah Philip, Wright Jason D, Freedberg Daniel E
Department of Medicine, Columbia University Medical Center, New York, NY.
Biomedical Informatics, New York-Presbyterian Hospital, New York, NY.
J Am Coll Surg. 2017 Nov;225(5):631-638.e3. doi: 10.1016/j.jamcollsurg.2017.08.010. Epub 2017 Oct 10.
Antibiotic-resistant infections have high rates of morbidity and mortality, and exposure to antibiotics is the crucial risk factor for development of antibiotic resistance. If surgical antibiotic prophylaxis (SAP) increases risk for antibiotic-resistant infections, prophylaxis may cause net harm, even if it decreases overall infection rates.
This retrospective cohort study included adults who underwent elective surgical procedures and developed infections within 30 postoperative days. Procedures from multiple disciplines were included if SAP was considered discretionary by current guidelines. Postoperative antibiotic-resistant infections were defined as positive culture results from any site within 30 postoperative days, showing intermediate or nonsusceptibility across 1 or more antibiotic classes. Surgical antibiotic prophylaxis included use of antibiotics within any class and at any dose from 1 hour before first incision until the end of the operation.
Among 689 adults with postoperative infections, 338 (49%) had postoperative resistant infections. Use of SAP was not associated with postoperative antibiotic-resistant infections (odds ratio [OR] 0.99; 95% CI 0.67 to 1.46). This result remained robust when the SAP definition was extended to antibiotics given within 4 hours before first incision (OR 0.94; 95% CI 0.63 to 1.40) and when the follow-up window was narrowed to 14 days (OR 0.82; 95% CI 0.50 to 1.34). Previous antibiotic-resistant infections were associated with risk for postoperative antibiotic-resistant infections (OR 1.81; 95% CI 1.16 to 2.83).
Use of SAP was not associated with risk for postoperative antibiotic-resistant infections in a large cohort of patients with postoperative infections. This provides important reassurance regarding use of surgical antibiotic prophylaxis.
抗生素耐药性感染具有很高的发病率和死亡率,而接触抗生素是抗生素耐药性产生的关键危险因素。如果外科手术预防性使用抗生素(SAP)会增加抗生素耐药性感染的风险,那么即使它能降低总体感染率,预防性使用抗生素也可能造成净危害。
这项回顾性队列研究纳入了接受择期手术且在术后30天内发生感染的成年人。如果当前指南认为SAP是可自由选择使用的,则纳入多个学科的手术。术后抗生素耐药性感染定义为术后30天内任何部位的培养结果呈阳性,显示对一种或多种抗生素类别耐药或不敏感。外科手术预防性使用抗生素包括从首次切开前1小时至手术结束使用任何类别、任何剂量的抗生素。
在689例术后感染的成年人中,338例(49%)发生了术后耐药性感染。使用SAP与术后抗生素耐药性感染无关(比值比[OR]0.99;95%可信区间0.67至1.46)。当将SAP的定义扩展到首次切开前4小时内使用的抗生素时(OR 0.94;95%可信区间0.63至1.40),以及当将随访窗口缩小至14天时(OR 0.82;95%可信区间0.50至1.34),该结果仍然稳健。既往抗生素耐药性感染与术后抗生素耐药性感染风险相关(OR 1.81;95%可信区间1.16至2.83)。
在一大群术后感染患者中,使用SAP与术后抗生素耐药性感染风险无关。这为外科手术预防性使用抗生素提供了重要的保证。